日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

International neuroblastoma risk group consortium: a model of networking for rare cancers

国际神经母细胞瘤风险组联盟:罕见癌症网络模式

Cohn, Susan L; London, Wendy B; Schleiermacher, Gudrun; Moreno, Lucas; Ambros, Inge M; Ambros, Peter F; Bagatell, Rochelle; Popovic, Maja Beck; Beiske, Klaus Hermann; Berthold, Frank; Birz, Suzi; Brisse, Hervé J; Brodeur, Garrett M; Brock, Penelope R; Burchill, Susan; Eggert, Angelika; Federico, Sara M; Fischer, Matthias; Furner, Brian T; Hero, Barbara; Machin, David; Kamijo, Takehiko; Matthay, Katherine K; Nakagawara, Akira; Naranjo, Arlene; Pötschger, Ulrike; Valteau-Couanet, Dominique; Watkins, Michael T; Irwin, Meredith S; Volchenboum, Samuel L; Park, Julie R; Pearson, Andrew D J

ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma

ESFT13:一项评估在标准化疗方案中加入窗口期和维持治疗治疗高危尤文氏肉瘤的 II 期研究

Gartrell, Jessica; Navid, Fariba; Yuan, Xiaomeng; Ness, Kirsten K; Dubrovin, Mikhail; Wang, Fang; Pan, Haitao; McCarville, Mary Beth; Shulkin, Barry L; Helmig, Sara; Krasin, Matthew J; Neel, Michael D; Davidoff, Andrew M; Mandrell, Belinda N; Levine, Deena R; Cai, Zhongheng; Bishop, Michael W; Pappo, Alberto S; Federico, Sara M

The Combination of PARP and Topoisomerase 1 Inhibitors Improves Radiation Therapy for Ewing Sarcoma

PARP抑制剂和拓扑异构酶1抑制剂联合应用可改善尤文氏肉瘤的放射治疗效果

Xie, Jia; Mellado-Lagarde, Marcia M; Blankenship, Kaley; Ganguly, Debolina; Twarog, Nathaniel R; Bianski, Brandon; Kieffer, Matthew; Atkinson, Stefan; Sheppard, Heather; Gartrell, Jessica; Cler, Samuel; Federico, Sara M; Stewart, Elizabeth A; Tinkle, Christopher L; Shelat, Anang A

Response to PARP Inhibition in BARD1-Mutated Refractory Neuroblastoma

BARD1突变难治性神经母细胞瘤对PARP抑制剂的反应

Cupit-Link, Margaret; Hagiwara, Kohei; Nagy, Matthew; Koo, Selene C; Orr, Brent A; Ruppin, Eytan; Easton, John; Zhang, Jinghui; Federico, Sara M

Treatment of High-Risk Neuroblastoma with Dinutuximab and Chemotherapy Administered in all Cycles of Induction

采用迪努妥昔单抗联合化疗治疗高危神经母细胞瘤,化疗在所有诱导治疗周期中均进行。

Cupit-Link, Margaret; Federico, Sara M

Venetoclax Penetrates the Blood Brain Barrier: A Pharmacokinetic Analysis in Pediatric Leukemia Patients

维奈托克可穿透血脑屏障:一项针对儿童白血病患者的药代动力学分析

Badawi, Mohamed; Menon, Rajeev; Place, Andrew E; Palenski, Tammy; Sunkersett, Gauri; Arrendale, Richard; Deng, Rong; Federico, Sara M; Cooper, Todd M; Salem, Ahmed Hamed

Clinical Response to a PARP Inhibitor and Chemotherapy in a Child with BARD1-Mutated Refractory Neuroblastoma: A Case Report

一例携带 BARD1 突变的难治性神经母细胞瘤患儿对 PARP 抑制剂和化疗的临床反应:病例报告

Cupit-Link, Maggie; Hagiwara, Kohei; Zhang, Jinghui; Federico, Sara M

Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A

采用化疗免疫疗法治疗新诊断的高危神经母细胞瘤患儿,疗效显著改善:一项使用hu14.18K322A的II期研究的最新结果

Furman, Wayne L; McCarville, Beth; Shulkin, Barry L; Davidoff, Andrew; Krasin, Matthew; Hsu, Chia-Wei; Pan, Haitao; Wu, Jianrong; Brennan, Rachel; Bishop, Michael W; Helmig, Sara; Stewart, Elizabeth; Navid, Fariba; Triplett, Brandon; Santana, Victor; Santiago, Teresa; Hank, Jacquelyn A; Gillies, Stephen D; Yu, Alice; Sondel, Paul M; Leung, Wing H; Pappo, Alberto; Federico, Sara M

A bridge over troubled water-Extending induction for high-risk neuroblastoma patients with poor end-of-induction response

跨越困境的桥梁——延长诱导治疗对诱导治疗结束时疗效不佳的高危神经母细胞瘤患者的治疗时间。

Federico, Sara M; Cash, Thomas

Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma

新辅助化疗对高危神经母细胞瘤影像学定义危险因素的影响

Mansfield, Sara A; McCarville, M Beth; Lucas, John T Jr; Krasin, Matthew J; Federico, Sara M; Santana, Victor M; Furman, Wayne L; Davidoff, Andrew M